NDC 51662-1392

PROCAINAMIDE HCI

Procainamide Hci

PROCAINAMIDE HCI is a Intramuscular; Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co Llc, Dba Healthfirst. The primary component is Procainamide Hydrochloride.

• Product ID: 51662-1392_9508d1a2-da9b-5480-e053-2a95a90a73c7
• NDC: 51662-1392
• Product Type: Human Prescription Drug
• Proprietary Name: PROCAINAMIDE HCI
• Generic Name: Procainamide Hci
• Dosage Form: Injection, Solution
• Route of Administration: INTRAMUSCULAR; INTRAVENOUS
• Marketing Start Date: 2019-10-16
• Marketing Category: ANDA / ANDA
• Application Number: ANDA089070
• Labeler Name: HF Acquisition Co LLC, DBA HealthFirst
• Substance Name: PROCAINAMIDE HYDROCHLORIDE
• Active Ingredient Strength: 500 mg/mL
• Pharm Classes: Antiarrhythmic [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 51662-1392-1

2 mL in 1 VIAL, MULTI-DOSE (51662-1392-1)

• Marketing Start Date: 2019-10-16
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 51662-1392-1 [51662139201]

PROCAINAMIDE HCI INJECTION, SOLUTION

• Marketing Category: ANDA
• Application Number: ANDA089070
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2019-10-16

Drug Details

Active Ingredients

Ingredient	Strength
PROCAINAMIDE HYDROCHLORIDE	500 mg/mL

Pharmacological Class

• Antiarrhythmic [EPC]

NDC Crossover Matching brand name "PROCAINAMIDE HCI" or generic name "Procainamide Hci"

NDC	Brand Name	Generic Name
51662-1334	PROCAINAMIDE HCI	PROCAINAMIDE HCI
51662-1392	PROCAINAMIDE HCI	PROCAINAMIDE HCI